Join
Live feed
·
PRReleasevia Quantisnow
Processa Pharmaceuticals Inc. logo

Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study

ByQuantisnow·Wall Street's wire, on your screen.
PCSA· Processa Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PCSA (Processa Pharmaceuticals Inc.) and more on Quantisnow.